Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 830

Results For "ED"

8418 News Found

Brinton triples production of COVID-19 drug Favipiravir
News | May 12, 2021

Brinton triples production of COVID-19 drug Favipiravir

Favipiravir is close to Remdesivir, Remdesivir is used to treat moderate to severe cases while Favipiravir is used to treat mild to moderate cases


CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating
News | May 11, 2021

CRISIL assigns 'Positive' outlook to Jubilant Pharmova's long-term rating

The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.


Alembic reports net profit of Rs. 71.94 Cr in Q4FY21
News | May 11, 2021

Alembic reports net profit of Rs. 71.94 Cr in Q4FY21

Alembic has reported total income of Rs.83.79 crores during the FY ended March 31, 2021


Remdesivir allocation made upto 16th May: Gowda
News | May 10, 2021

Remdesivir allocation made upto 16th May: Gowda

State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals


Jubilant Pharma wins over Bracco's legal appeals in the US Court of Appeals
News | May 10, 2021

Jubilant Pharma wins over Bracco's legal appeals in the US Court of Appeals

Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office


Cipla signs agreement with Lilly to expand access to COVID-19 treatment in India
News | May 10, 2021

Cipla signs agreement with Lilly to expand access to COVID-19 treatment in India

Baricitinib was issued a restricted emergency use approval by the Central Drugs Standard Control Organization (CDSCO)


Sun Pharma signs agreement with Eli Lilly for expanding access to Baricitinib
News | May 10, 2021

Sun Pharma signs agreement with Eli Lilly for expanding access to Baricitinib

Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19


Lupin enters into agreement with Lilly to expand access for COVID-19
News | May 10, 2021

Lupin enters into agreement with Lilly to expand access for COVID-19

Baricitinib is an oral medication that was earlier registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients.


Roche receives emergency use authorisation of COVID-19 drug
News | May 07, 2021

Roche receives emergency use authorisation of COVID-19 drug

This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India


Lonza announces expansion plans for mammalian manufacturing facilities
News | May 07, 2021

Lonza announces expansion plans for mammalian manufacturing facilities

The facility is expected to be completed in 2024